Epidermal growth factor receptor: An independent predictor of survival in astrocytic tumors given definitive irradiation

International Journal of Radiation Oncology Biology Physics

Volumn 34, Issue 4, 1996, Pages 809-815

  Zhu, An ^a   Shaeffer, James ^a   Leslie, Susan ^a   Kolm, Paul ^a   El Mahdi, Anas M ^a  

^a EASTERN VIRGINIA MEDICAL SCHOOL   (United States)

Author keywords

Astrocytic tumors; Epidermal growth factor receptor; Immunohistochemistry; Recurrence free survival; Survival

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR;

ADULT; ARTICLE; ASTROCYTOMA; CANCER RECURRENCE; CANCER SURVIVAL; FEMALE; GENE EXPRESSION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; PREDICTION; PRIORITY JOURNAL; PROGNOSIS;

EID: 0029983510     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/0360-3016(95)02184-1     Document Type: Article

References (24)

1. Agosti, R. M.; Leuthold, M.; Gullick, W. J.; Yasargil, M. G.; Wiestler, O. D. Expression of the epidermal growth factor receptor in astrocytic tumours is specifically associated with glioblastoma multiforme. Virchows Arch. A. Pathol. Anat. 420:321-325; 1992.
2. Bigner, S. H.; Vogelstein, B. Cytogenetics and molecular genetics of malignant gliomas and medulloblastomas. Brain Pathol. 1:12-18; 1990.
3. Burger, P. C.; Vogel, F. S.; Green, S. B.; Strike, T. A. Glioblastoma multiforme and anaplastic astrocytoma: Pathologic criteria and prognostic implications. Cancer 56:1106-1111; 1985.
4. Coons, S. W.; Johnson, P. C.; Pearl, D. K. Prognostic significance of flow cytometry deoxyribonucleic acid analysis of human astrocytomas. Neurosurgery 35:119-126; 1994.
5. Curran, W. J., Jr.; Scott, C. B.; Horton, J.; Nelson, J. S.; Weinstein, A. S.; Fischbach, A. J.; Chang, C. H.; Rotman, M.; Asbell, S. O.; Krisch, R. E.; Nelson, D. F. Recursive partitioning analysis in three radiation therapy oncology group malignant glioma trials. J. Natl. Cancer Inst. 85:704-710; 1993.
6. Daumas-Duport, C.; Scheithauer, B.; O'Fallon, J.; Kelly, P. Grading of astrocytomas. A simple and reproducible method. Cancer 62:2152-65; 1988.
7. Duncan, G. G.; Goodman, G. B.; Ludgate, C. M.; Rheaume, D. E. The treatment of adult supratentorial high grade astrocytomas. J. Neuro-oncology 13:63-72; 1992.
8. Hall, W. A.; Merrill, M. J.; Walbridge, S.; Youle, R. J. Epidermal growth factor receptors on ependymomas and other brain tumors. J. Neurosurg. 72:641-646, 1990.
9. Jaros, E.; Perry, R. H.; Adam, L.; Kelly, P. J.; Crawford, P. J.; Kalbag, R. M.; Mendelow, A. D.; Sengupta, R. P.; Pearson, A. D. J. Prognostic implications of p53 protein, epidermal growth factor receptor and Ki-67 brain tumours. Br. J. Cancer 66:373-385, 1992.
10. Kim, T. S.; Halliday, A. L.; Hedley-Whyte, E. T.; Convery, K. Correlates of survival and the Daumas-Duport grading system for astrocytomas. J. Neurosurg. 74:27-37; 1991.
11. Louis, D. N.; Rubio, M. P.; Correa, K. M.; Gusella, J. F.; von Deimling, A. Molecular genetics of pediatric brain stem gliomas, application of PCR techniques to small and archival brain tumor specimens. J. Neuropathol. Exp. Neurol. 52:507-515; 1993.
12. Maruno, M.; Kovach, J. S.; Kelly, P. J.; Yanagihara, T. Transforming growth factor-α, epidermal growth factor receptor, and proliferating potential in benign and malignant gliomas. J. Neurosurg. 75:97-102; 1991.
13. North, B.; Reilly, P.; Blumbergs, P.; Roder, D.; Esterman, A. Malignant astrocytoma in South Australia: Treatment and case survival. Med. J. Aust. 153:250-254; 1990.
14. Philippon, J. H.; Clemenceau, S. H.; Fauchon, F. H.; Foncin, J. F. Supratentorial low-grade astrocytomas in adults. Neurosurgery 32:554-559; 1993.
15. Salmon, I.; Dewitte, O.; Pasteels, J. L.; Flament-Durand, J.; Brotchi, J.; Vereerstraeten, P.; Kiss, R. Prognostic scoring in adult astrocytic tumors using patient age, histopathologic grade and DNA histogram type. J. Neurosurg. 80:877-883; 1994.
16. Salmon, I.; Kiss, R.; Dewitte, O.; Gras, T.; Pasteels, J. L.; Brotchi, J.; Flament-Durand, J. Histopathologic grading and DNA ploidy in relation to survival among 206 adult astrocytic tumor patients. Cancer 70:538-546; 1992.
17. Sandberg-Wollheim, M.; Malmström, P.; Strömblad, L. G.; Anderson, H.; Borgström, S.; Brun, A.; Cronqvist, S.; Hougaard, K.; Salford, L. G. A randomized study of chemotherapy with procarbazine, vincristine and lomustine with and without radiation therapy for astrocytoma Grade 3 and/or 4. Cancer 68:22-29; 1991.
18. Schold, S. C.; Herndon, J. E.; Burger, P. C.; Halperin, E. C.; Vick, N. A.; Cairncross, J. G.; Macdonald, D. R.; Dropcho, E. J.; Morawetz, R.; Bigner, D. D.; Mahaley, M. S. Randomized comparison of diaziquone and carmustine in the treatment of adults with anaplastic glioma. J. Clin. Oncol. 11:77-83; 1993.
19. Shaeffer, J.; Zhu, A.; Yu, J.; Kolm, P.; El-Mahdi, A. M. Correlation of DNA content and histologic grade with survival of patients with astrocytic gliomas. Cancer Mol. Biol. 1:305-310; 1994.
20. Shibamoto, Y.; Kitakabu, Y.; Takahashi, M.; Yamashita, J.; Oda, Y.; Kikuchi, H.; Abe, M. Supratentorial low-grade astrocytoma. Cancer 72:190-195; 1993.
21. Smith, D. F.; Hutton, J. L.; Foy, P. M.; Shaw, M. D. M.; Williams, I. R.; Chadwick, D. W. The prognosis of primary intracerebral tumours presenting with epilepsy: The outcome of medical and surgical management. J. Neurol. Neurosurg. Psychiatry 54:915-920; 1991.
22. Soffietti, R.; Chiò, A.; Giordana, M. T.; Vasario, E.; Schiffer, D. Prognostic factors in well-differentiated cerebral astrocytomas in the adult. Neurosurgery 24:686-692; 1989.
23. von Deimling, A.; Louis, D. N.; von Ammon, K.; Petersen, I.; Hoell, T.; Chung, R. Y.; Martuza, R. L.; Schoenfeld, D. A.; Yasargil, M. G.; Wiestler, O. D.; Seizinger, B. R. Association of epidermal growth factor receptor gene amplification with loss of chromosome 10 in human glioblastoma multiforme. J. Neurosurg. 77:295-301; 1992.
24. Winer, B. J. Statistical principles in experimental design, 2nd ed. New York: McGraw-Hill; 1971.